{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:03:57Z","timestamp":1790543037047,"version":"4.1.0"},"reference-count":33,"publisher":"Biomedical Research Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2025,5,23]]},"DOI":"10.2220\/biomedres.46.83","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:08:15Z","timestamp":1748297295000},"page":"83-92","source":"Crossref","is-referenced-by-count":10,"title":["Finerenone alleviates the high glucose-induced fibrosis in HK-2 cells by inhibiting EMT via the TGF-\u03b21\/Smads signaling"],"prefix":"10.2220","volume":"46","author":[{"given":"Yanqiao","family":"WANG","sequence":"first","affiliation":[{"name":"Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"LIU","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"ZHENG","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanlin","family":"ZHENG","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoji","family":"CHEN","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxin","family":"ZHANG","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Agarwal R, Filippatos G, Pitt B, Anker SD, Rossing P, <i>et al.<\/i> (2022) Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. <i>Eur Heart J<\/i> <b>43<\/b>, 474\u2013484.","DOI":"10.1093\/eurheartj\/ehab777"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Akrida I, Bravou V and Papadaki H (2022) The deadly cross-talk between Hippo pathway and epithelial\u2013mesenchymal transition (EMT) in cancer. <i>Mol Biol Rep<\/i> <b>49<\/b>, 10065\u201310076.","DOI":"10.1007\/s11033-022-07590-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, <i>et al.<\/i> (2020) Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetes. <i>N Engl J Med<\/i> <b>383<\/b>, 2219\u20132229.","DOI":"10.1056\/NEJMoa2025845"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Barriere G, Fici P, Gallerani G, Fabbri F and Rigaud M (2015) Epithelial mesenchymal transition: a double-edged sword. <i>Clin Transl Med<\/i> <b>4<\/b>, 1\u20136.","DOI":"10.1186\/s40169-015-0055-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bloomgarden Z and Handelsman Y (2023) Diabetes epidemiology and its implications. In: <i>Lipoproteins in Diabetes Mellitus<\/i>. pp 881\u2013890, Springer.","DOI":"10.1007\/978-3-031-26681-2_31"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cao Y, Lin JH, Hammes HP and Zhang C (2022) Cellular phenotypic transitions in diabetic nephropathy: an update. <i>Front Pharmacol<\/i> <b>13<\/b>, 1038073.","DOI":"10.3389\/fphar.2022.1038073"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Deshmukh AP, Vasaikar SV, Tomczak K, Tripathi S, Den Hollander P, <i>et al.<\/i> (2021) Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proc Natl Acad Sci USA <b>118<\/b>, e2102050118.","DOI":"10.1073\/pnas.2102050118"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dityatev A, Schachner M and Sonderegger P (2010) The dual role of the extracellular matrix in synaptic plasticity and homeostasis. <i>Nat Rev Neurosci<\/i> <b>11<\/b>, 735\u2013746.","DOI":"10.1038\/nrn2898"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Droebner K, Pavkovic M, Grundmann M, Hartmann E, Goea L, <i>et al.<\/i> (2021) Direct blood pressure-independent anti-fibrotic effects by the selective nonsteroidal mineralocorticoid receptor antagonist finerenone in progressive models of kidney fibrosis. <i>Am J Nephrol<\/i> <b>52<\/b>, 588\u2013601.","DOI":"10.1159\/000518254"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Gwon MG, An HJ, Kim JY, Kim WH, Gu H, <i>et al.<\/i> (2020) Anti\u2010fibrotic effects of synthetic TGF\u2010\u03b21 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial\u2010mesenchymal transitions. <i>FASEB J<\/i> <b>34<\/b>, 333\u2013349.","DOI":"10.1096\/fj.201901307RR"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Isshiki T, Naiel S, Vierhout M, Otsubo K, Ali P, <i>et al.<\/i> (2024) Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases. <i>Pharmacol Ther<\/i> <b>253<\/b>, 108578.","DOI":"10.1016\/j.pharmthera.2023.108578"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Katsuno Y and Derynck R (2021) Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-\u03b2 family. <i>Dev Cell<\/i> <b>56<\/b>, 726\u2013746.","DOI":"10.1016\/j.devcel.2021.02.028"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lavall D, Jacobs N, Mahfoud F, Kolkhof P, Bo\u0308hm M, <i>et al.<\/i> (2019) The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling. <i>Biochem Pharmacol<\/i> <b>168<\/b>, 173\u2013183.","DOI":"10.1016\/j.bcp.2019.07.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Li KY, Tam CHT, Liu H, Day S, Lim CKP, <i>et al.<\/i> (2023) DNA methylation markers for kidney function and progression of diabetic kidney disease. <i>Nat Commun<\/i> <b>14<\/b>, 2543.","DOI":"10.1038\/s41467-023-37837-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Liao W, Wen Y, Wang J, Zhao M, Chen N, <i>et al.<\/i> (2023) Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt\/\u03b2-catenin signaling pathway. <i>J Ethnopharmacol<\/i> <b>302<\/b>, 115885.","DOI":"10.1016\/j.jep.2022.115885"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Liu L, Sun Q, Davis F, Mao J, Zhao H, <i>et al.<\/i> (2022) Epithelial\u2013mesenchymal transition in organ fibrosis development: current understanding and treatment strategies. <i>Burns Trauma<\/i> <b>10<\/b>, tkac011.","DOI":"10.1093\/burnst\/tkac011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Nikolov A and Popovski N (2022) Extracellular matrix in heart disease: Focus on circulating collagen type I and III derived peptides as biomarkers of myocardial fibrosis and their potential in the prognosis of heart failure: A concise review. <i>Metabolites<\/i> <b>12<\/b>, 297.","DOI":"10.3390\/metabo12040297"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Noguchi R, Kaji K, Namisaki T, Moriya K, Kawaratani H, <i>et al.<\/i> (2020) Novel oral plasminogen activator inhibitor-1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats. <i>Mol Med Rep<\/i> <b>22<\/b>, 2948\u20132956.","DOI":"10.3892\/mmr.2020.11360"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, <i>et al.<\/i> (2021) Cardiovascular events with finerenone in kidney disease and type 2 diabetes. <i>New Engl J Med<\/i> <b>385<\/b>, 2252\u20132263.","DOI":"10.1056\/NEJMoa2110956"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Rahman MH, Biswas P, Dey D, Hannan MA, Sahabuddin M, <i>et al.<\/i> (2022) An in-silico identification of potential flavonoids against kidney fibrosis targeting TGF\u03b2R-1. <i>Life<\/i> <b>12<\/b>, 1764.","DOI":"10.3390\/life12111764"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Sheng L and Zhuang S (2020) New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis. <i>Front Physiol<\/i> <b>11<\/b>, 569322.","DOI":"10.3389\/fphys.2020.569322"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Song Y, Lv S, Wang F, Liu X, Cheng J, <i>et al.<\/i> (2020) Overexpression of BMP-7 reverses TGF-\u03b21-induced epithelial-mesenchymal transition by attenuating the Wnt3\/\u03b2-catenin and TGF-\u03b21\/Smad2\/3 signaling pathways in HK-2 cells. <i>Mol Med Rep<\/i> <b>21<\/b>, 833\u2013841.","DOI":"10.3892\/mmr.2019.10875"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Sun T, Wang B, Wang Z, Chen L, Li Z, <i>et al.<\/i> (2025) Apigenin inhibits epithelial mesenchymal transition in renal tubular epithelial cells through PI3K\/AKT and NF-\u03baB pathways for treating renal fibrosis. <i>Gene<\/i> <b>934<\/b>, 149056.","DOI":"10.1016\/j.gene.2024.149056"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Supabphol S, Seubwai W, Wongkham S and Saengboonmee C (2021) High glucose: an emerging association between diabetes mellitus and cancer progression. <i>J Mol Med<\/i> <b>99<\/b>, 1175\u2013 1193.","DOI":"10.1007\/s00109-021-02096-w"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Tang J, Liu F, Cooper ME and Chai Z (2022) Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-\u03b2) and related molecules. <i>Expert Opin Ther Targets<\/i> <b>26<\/b>, 721\u2013738.","DOI":"10.1080\/14728222.2022.2133698"},{"key":"26","doi-asserted-by":"crossref","unstructured":"van Soldt BJ and Cardoso WV (2020) Hippo\u2010Yap\/Taz signaling: Complex network interactions and impact in epithelial cell behavior. <i>Wiley Interdiscip Rev Dev Biol<\/i> <b>9<\/b>, e371.","DOI":"10.1002\/wdev.371"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Venugopal H, Hanna A, Humeres C and Frangogiannis NG (2022) Properties and functions of fibroblasts and myofibroblasts in myocardial infarction. <i>Cells<\/i> <b>11<\/b>, 1386.","DOI":"10.3390\/cells11091386"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Xu D, Moru P, Liao K, Song W, Yang P, <i>et al.<\/i> (2024) High glucose-induced senescence contributes to tubular epithelial cell damage in diabetic nephropathy. <i>Exp Gerontol<\/i> <b>197<\/b>, 112609.","DOI":"10.1016\/j.exger.2024.112609"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yao L, Liang X, Liu Y, Li B, Hong M, <i>et al.<\/i> (2023) Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K\/Akt\/eNOS signaling pathway in diabetic tubulopathy. <i>Redox Biol<\/i> <b>68<\/b>, 102946.","DOI":"10.1016\/j.redox.2023.102946"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhang H-f, Liu H-m, Xiang J-y, Zhou X-c, Wang D, <i>et al.<\/i> (2023) Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXR\u03b1 expression and activation. <i>Acta Pharmacol Sinica<\/i> <b>44<\/b>, 1051\u20131065.","DOI":"10.1038\/s41401-022-00997-1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Zhang H, Xie J, Hao C, Li X, Zhu D, <i>et al.<\/i> (2023) Finerenone in patients with chronic kidney disease and type 2 diabetes: The FIDELIO-DKD Subgroup from China. <i>Kidney Dis (Basel)<\/i> <b>9<\/b>, 498\u2013506.","DOI":"10.1159\/000531997"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Zhao H, Zhang H-L and Jia L (2023) High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies. <i>Biomed Pharmacother<\/i> <b>165<\/b>, 115246.","DOI":"10.1016\/j.biopha.2023.115246"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zhou M-s, Zheng S-y, Chen C, Li X, Zhang Q, <i>et al.<\/i> (2024) Gene expression analysis to identify mechanisms underlying improvement of myocardial fibrosis by finerenone in SHR. <i>Biochem Pharmacol<\/i> <b>220<\/b>, 115975.","DOI":"10.1016\/j.bcp.2023.115975"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/46\/3\/46_83\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:37:29Z","timestamp":1748666249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/46\/3\/46_83\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.46.83","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}